Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

A gain in chromosome 1q (+1q) is among the most common cytogenetic abnormalities in multiple myeloma (MM). It is unclear whether +1q is independently associated with decreased overall survival (OS). The objective of this study was to evaluate the impact of +1q on clinical characteristics, treatment...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Abdallah, Nadine, Greipp, Patricia, Kapoor, Prashant, Gertz, Morie A., Dispenzieri, Angela, Baughn, Linda B., Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Go, Ronald S., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam, Lin, Yi, Leung, Nelson, Kourelis, Taxiarchis, Warsame, Rahma, Siddiqui, Mustaqeem, Lust, John, Kyle, Robert A., Bergsagel, Leif, Ketterling, Rhett, Rajkumar, S. Vincent, Kumar, Shaji K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2020
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422105/
https://ncbi.nlm.nih.gov/pubmed/32750129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002218
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak